Economic consequences of the demography of mrsa patients and the impact of broad-spectrum antimicrobials

Applied Health Economics and Health Policy

Volumn 10, Issue 4, 2012, Pages 227-234

  Kaier, K ^a   Moog, S ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anti infectives; Antimicrobial resistance; Elderly; Health policy; Methicillin resistant Staphylococcus aureus infections; Productivity costs.

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CEPHALOSPORIN; LINCOSAMIDE; MACROLIDE; QUINOLONE DERIVATIVE;

AGE DISTRIBUTION; AGING; BACTEREMIA; BACTERIAL COLONIZATION; CLINICAL EFFECTIVENESS; DISEASE PREDISPOSITION; DISINFECTION; DRUG EFFICACY; DRUG USE; EPIDEMIOLOGY; GERMAN DEMOCRATIC REPUBLIC; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RATE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRODUCTIVITY; REIMBURSEMENT; REVIEW; TEACHING HOSPITAL;

AGE DISTRIBUTION; AGED; ANTI-INFECTIVE AGENTS; CROSS INFECTION; DRUG UTILIZATION; EMPLOYMENT; GERMANY; HANDWASHING; HOSPITALS, TEACHING; HUMANS; INPATIENTS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POPULATION DYNAMICS; STAPHYLOCOCCAL INFECTIONS;

EID: 84862566301     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.2165/11631350-000000000-00000     Document Type: Review

References (36)

1. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003 Jun 1; 36 (11): 1433-7 (Pubitemid 36702878)
2. Kaier K, Wilson C, Chalkley M, et al. Health and economic impacts of antibiotic resistance in european hospitals: outlook on the BURDEN project. Infection 2008 Sep 15; 36 (5): 492-4
3. Smith RD, Yago M, Millar M, et al. Assessing the macroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistance. J Health Econ 2005 Nov; 24 (6): 1055-75 (Pubitemid 41476212)
4. Smith RD, Yago M, Millar M, et al. A macroeconomic approach to evaluating policies to contain antimicrobial resistance: a case study of methicillin-resistant Staphylococcus aureus (MRSA). Appl Health Econ Health Policy 2006; 5 (1): 55-65 (Pubitemid 43927200)
5. Shorr AF. Epidemiology and economic impact of methicillin- resistant Staphylococcus aureus: review and analysis of the literature. Pharmacoeconomics 2007; 25 (9): 751-68 (Pubitemid 47481640)
6. Paladino JA, Sunderlin JL, Price CS, et al. Economic consequences of antimicrobial resistance. Surg Infect 2002; 3 (3): 259-67 (Pubitemid 36013618)
7. Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 2008; 6 (5): 751-63
8. Resch A, Wilke M, Fink C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ 2009 Jan 1; 10 (3): 287-97
9. Kaier K, Frank U. Measuring the externality of antibacterial use from promoting antimicrobial resistance. Pharmacoeconomics 2010; 28 (12): 1123-8
10. Coast J, Smith RD, Millar MR. An economic perspective on policy to reduce antimicrobial resistance. Soc Sci Med 1998 Jan; 46 (1): 29-38 (Pubitemid 28014365)
11. Fischer C, Laxminarayan R. Sequential development and exploitation of an exhaustible resource: do monopoly rights promote conservation? J Environ Econ Manage 2005 May; 49 (3): 500-15 (Pubitemid 40607876)
12. Horowitz JB, Moehring HB. How property rights and patents affect antibiotic resistance. Health Econ 2004 Jun; 13 (6): 575-83 (Pubitemid 38787149)
13. Kambou G, Devarajan S, Over M. The economic impact of AIDS in an African country: simulations with a computable general equilibrium model of Cameroon. J Afr Econ 1992; 1 (1): 109-30
14. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002; 415 (6872): 680-5 (Pubitemid 34136401)
15. Barlow R. The economic effects of malaria eradication. Am Econ Rev 1967; 57 (2): 130-48
16. Bloom DE, Mahal AS. Does the AIDS epidemic threaten economic growth? J Econometr 1997; 77 (1): 105-24 (Pubitemid 127381048)
17. Witte W. Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know? Clin Microbiol Infect 2009; 15: 17-25
18. Federal Statistical Office. Bevö lkerung und Erwerbstä tigkeit 2008. Fachserie 1, Reihe 1.3 2010 [online]. Available from URL: https://www.destatis.de/DE/Publikationen/Thematisch/Bevoelkerung/ Bevoelkerungsstand/Bevoelkerungsfortschreib ung2010130087004.pdf [Accessed 2012 Apr 19]
19. German Nosocomial Infection Surveillance System. Reference data MRSA-KISS [online]. Available from URL: http://www.nrz-hygiene.de [Accessed 2012 Apr 5]
20. Federal Statistical Office. Grunddaten der Krankenhä user 2008. Fachserie 12, Reihe 6.1.1 2010 [online]. Available from URL: https://www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/Krankenhaeuser/ GrunddatenKrankenhaeuser 2120611087004.pdf [Accessed 2012 Apr 19]
21. Levy SB. The antibiotic paradox: how miracle drugs are destroying themiracle.NewYork, London: PlenumPress, 1992
22. Coast J, Smith RD, Millar MR. Superbugs: should antimicrobial resistance be included as a cost in economic evaluation? Health Econ 1996 May; 5 (3): 217-26
23. Elbasha EH. Deadweight loss of bacterial resistance due to overtreatment. Health Econ 2003 Feb; 12 (2): 125-38 (Pubitemid 36204169)
24. Phelps CE. Bug/drug resistance: sometimes less is more. Med Care 1989 Feb; 27 (2): 194-203
25. Herrmann M. Monopoly pricing of an antibiotic subject to bacterial resistance. J Health Econ 2010 Jan; 29 (1): 137-50
26. Rudholm N. Economic implications of antibiotic resistance in a global economy. J Health Econ 2002 Nov; 21 (6): 1071-83 (Pubitemid 35365706)
27. Aldeyab MA, Monnet DL, Lopez-Lozano JM, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillinresistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 2008 May 7; 62 (3): 593-600
28. Kaier K, Hagist C, Frank U, et al. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 2009; 30 (4): 346-53
29. Kaier K, Frank U. An econometric view of the dynamic relationship between antibiotic consumption, hand disinfection and methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2009; 63 (3): 630-1
30. Vernaz N, Sax H, Pittet D, et al. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 2008 May 8; 62 (3): 601-7
31. Organisation for Economic Cooperation and Development (OECD). OECD health data, 2006. Paris: OECD, 2010
32. Simonsen L, Conn LA, Pinner RW, et al. Trends in infectious disease hospitalizations in the United States, 1980- 1994. Arch Intern Med 1998; 158 (17): 1923-8 (Pubitemid 28440866)
33. Cohen ML. Changing patterns of infectious disease. Nature 2000; 406 (6797): 762-7
34. Federal Statistical Office. Bevö lkerungDeutschlands bis 2060. 12. koordinierte Bevö lkerungsvorausberechnung 2009 [online]. Available from URL: https://www.destatis.de/DE/Publikationen/Thematisch/Bevoelkerung/ Vorausberechnung Bevoelkerung/BevoelkerungDeutschland2060Presse51242 04099004.pdf [Accessed 2012 Apr 19]
35. Eurostat. Statistical database, Code: tsiem030, 2012 [online]. Available from URL: http://epp.eurostat.ec.europa.eu/portal/page/portal/product-details/ dataset?p-product-code =TSIEM030 [Accessed 2012 Apr 19]
36. Werblow A, Felder S, Zweifel P. Population ageing and health care expenditure: a school of 'red herrings'? Health Econ 2007; 16 (10): 1109-26 (Pubitemid 47534736)